Abstract :
Background: Polycystic ovary syndrome (PCOS) is a most common clinical-hormonal women-affecting disorder, often leading to chronic health issues beyond reproductive challenges. Women with PCOS experience irregular menstrual cycles along with elevated androgen levels; however, also associated with a high risk of chronic clinical-conditions such as Type 1 and Type 2 diabetes, and cardiovascular disease (CVD) due to underlying metabolic disturbances. This study investigates the health risks and complications associated with PCOS, including diabetes, cardiovascular disease, and fertility problems, aiming to develop improved management strategies.
Materials and Methods: This cross-sectional study was performed with 200 PCOS-diagnosed women and three hundred age-matched controls without PCOS. Data was collected from different sources like- Medical records, Laboratory tests, and Interviews with patients, and also from Body mass index(BMI), Blood glucose, Insulin levels, Cholesterol profile, C-reactive protein(CRP), Menstrual history, and Cardiovascular health markers. Statistical analysis was performed to compare the two groups through SPSS 20.0.
Results: The study revealed significantly higher rates of insulin resistance (72% vs. 25%) and Type 2 diabetes(35% vs. 10%) among PCOS-women. Additionally, CVD risk factors including hypertension (45% vs. 20%), abnormal cholesterol levels (60% vs. 30%), and elevated CRP levels were more prevalent in the Group I. Fertility issues were also more common in the Group I (with 80% experiencing anovulation and 50% reporting infertility) compared to 10% in the Group II.
Conclusion: PCOS is a significant clinical-risk factor for many types of diseases like Diabetes, CVD, infertility, etc. Effective management requires a comprehensive approach involving lifestyle modifications, medications, and regular screening and monitoring of PCOS to reduce risks of disease and also improve the health of women with PCOS.
Keyword :
PCOS, Insulin resistance, Cardiovascular disease, Infertility, Metabolic syndrome.